Home Medicine Association of vitamin B12, folate and homocysteine with functional and pathological characteristics of the elderly in a mountainous village in Sicily
Article
Licensed
Unlicensed Requires Authentication

Association of vitamin B12, folate and homocysteine with functional and pathological characteristics of the elderly in a mountainous village in Sicily

  • Rosario Sebastiano Spada , Giuseppe Stella , Santa Calabrese , Paolo Bosco , Guido Anello , Rosa-Maria Guéant-Rodriguez , Antonino Romano , Lahoucine Benamghar , Thierry Fontaine and Jean-Louis Guéant
Published/Copyright: February 1, 2007
Clinical Chemistry and Laboratory Medicine (CCLM)
From the journal Volume 45 Issue 2

Abstract

Background: Homocysteine is associated with age, folate and vitamin B12. Our study investigated the functional and clinical characteristics of the elderly (aged 60–85 years) of San Teodoro, a village in Central Sicily, and evaluated associations with vitamin B12, folate and homocysteine.

Methods: Subjects (n=280) were examined after door-to-door recruitment using interview, physician examination and laboratory tests.

Results: A total of 19.3% of the population had a low blood level of folate (<7 nmol/L) and 3.2% had low vitamin B12 concentration (<100 pmol/L). The level of dependency, determined by the Barthel index, influenced homocysteine blood levels (p<0.0001), independent of age (p<0.0001), folate (p=0.0028) and vitamin B12 (p=0.0165). Homocysteine was significantly associated with stroke (p=0.0027) and peripheral arterial vascular disease (p=0.0001), but not with myocardial infarction, angina pectoris, venous thrombosis or cancer. Vitamin B12 was lower in myocardial infarction and higher in diabetes and venous thrombosis compared to the other diseases.

Conclusions: The prevalence of deficits in folate and vitamin B12 was paradoxically high in the mountainous northeastern area of Sicily. Our study also underlines the association of homocysteine with dependency of the elderly and with stroke and peripheral arteriopathy.

Clin Chem Lab Med 2007;45:136–42.

:

Corresponding author: Rosario Sebastiano Spada, MD, Geriatric Unit, “Oasi” Institute for Research on Mental Retardation and Brain Aging (IRCCS), Via Conte Ruggero, 73, 94018 Troina (EN), Italy Phone: +39-0935-653966, Fax: +39-0935-936694,

References

1. Beer J, De Jong A. National population scenarios for countries of the European Economic Area. Maandstat Bevolking1996;44:7–19.Search in Google Scholar

2. Istituto Nazionale di Statistica (ISTAT). Nota informative 1 agosto, 2006.Search in Google Scholar

3. Bollander-Gouaille C. Focus on homocysteine and the vitamins involved in its metabolism, 2nd ed. Paris: Springer-Verlag, 2002.10.1007/978-2-8178-0845-1Search in Google Scholar

4. Folstein MF, Folstein SE, McHugh PR. “Mini-Mental State”: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res1975;12:189–98.10.1016/0022-3956(75)90026-6Search in Google Scholar

5. Sunderland T, Hill JL, Mellow AM. Clock drawing in Alzheimer's disease. J Am Geriatr Soc1989;37:725–9.10.1111/j.1532-5415.1989.tb02233.xSearch in Google Scholar

6. Bosc M, Dubini A, Polin V. Development and validation of a social functioning scale, the Social Adaptation Self-evaluation Scale. Eur Neuropsychopharmacol1997;7(Suppl 1):S57–70.10.1016/S0924-977X(97)00420-3Search in Google Scholar

7. Lemyre L, Tessier R, Fillion L. Mesure du stress psychologique (M.S.P.): Manuel d'utilisation. Québec, Canada: Behaviora Inc., 1990.Search in Google Scholar

8. Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist1996;9:179–86.10.1093/geront/9.3_Part_1.179Search in Google Scholar

9. Shah S, Vanclav F, Cooper B. Improving the sensitivity of the Barthel index for stroke rehabilitation. J Clin Epidemiol1989;42:703–9.10.1016/0895-4356(89)90065-6Search in Google Scholar

10. Rutten A, Vuillemin A, Ooijendijk WT, Schena F, Sjostrom M, Stahi T, et al. Physical activity monitoring in Europe. The European Physical Activity Surveillance System (EUPASS) approach and indicator testing. Public Health Nutr2003;6:377–84.10.1079/PHN2002449Search in Google Scholar PubMed

11. Newman AB. Peripheral arterial disease: insights from population studies of older adults. J Am Geriatric Soc2000;48:1157–62.10.1111/j.1532-5415.2000.tb04795.xSearch in Google Scholar

12. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th ed. Washington, DC: APA Press, 1994.Search in Google Scholar

13. Brazzelli M, Capitani E, Della Sala E, Spinnler H, Zuffi M. A neuropsychological instrument adding to the description of patients with suspected cortical dementia: the Milan overall dementia assessment. J Neurosurg Psychiatry1994;57:1510–7.10.1136/jnnp.57.12.1510Search in Google Scholar PubMed PubMed Central

14. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology1984;34:939–44.10.1212/WNL.34.7.939Search in Google Scholar PubMed

15. Roman GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology1993;43:250–60.10.1212/WNL.43.2.250Search in Google Scholar

16. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol1999;56:303–8.10.1001/archneur.56.3.303Search in Google Scholar PubMed

17. Tanner CM, Aston DA. Epidemiology of Parkinson's disease and akinetic syndromes. Curr Opin Neurol2000;13:427–30.10.1097/00019052-200008000-00010Search in Google Scholar PubMed

18. Morgante I, Rocca WA, Di Rosa AE, De Domenico P, Gricoletto F, Meneghini F. Prevalence of Parkinson's disease and other types of parkinsonism: a door-to-door survey in three Sicilian municipalities. Neurology1992;42:1901–7.10.1212/WNL.42.10.1901Search in Google Scholar PubMed

19. Launer LJ, Andersen K, Dewey ME, Letenneur L, Ott A, Amaducci LA. Rates and risk factors for dementia and Alzheimer's disease: results from EURODEM pooled analyses. EURODEM Incidence Research Group and Work Groups. European Studies of Dementia. Neurology1999;52:78–84.10.1212/WNL.52.1.78Search in Google Scholar PubMed

20. Gorelick PB. Risk factors for vascular dementia and Alzheimer disease. Stroke2004;35(Suppl 1):2620–2.10.1161/01.STR.0000143318.70292.47Search in Google Scholar PubMed

21. Ferini-Strambi L, Marcone A, Garancini P, Danelon F, Zamboni M, Massussi P, et al. Dementing disorders in north Italy: prevalence study in Vescovato, Cremona Province. Eur J Epidemiol1997;13:201–4.10.1023/A:1007340727385Search in Google Scholar

22. Principe M, Casini AR, Ferretti C, Lattanzio MT, Fiorelli M, Culasso F. Prevalence of dementia in an elderly rural population: effect of age, sex and education. J Neurol Neurosurg Psychiatry1996;60:628–33.10.1136/jnnp.60.6.628Search in Google Scholar PubMed PubMed Central

23. Petersen RC, Stevens JC, Ganguli M, Tangalos EG, Cummings JL, DeKosky ST. Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology2001;56:1133–42.10.1212/WNL.56.9.1133Search in Google Scholar

24. Di Carlo A, Launer LJ, Breteler MM, Fratiglioni L, Lobo A, Martinez-Lage J, et al. Frequency of stroke in Europe: a collaborative study of population-based cohorts. ILSA Working Group and the Neurologic Disease in the Elderly Research Group. Italia Longitudinal Study on Aging. Neurology2000;54(Suppl 5):S28–S33.Search in Google Scholar

25. Guéant-Rodriguez RM, Guéant JL, Debard R, Thirion S, Xiao Hong L, Bronowicki JP, et al. Prevalence of methylenetetrahydrofolate reductase 677T and 1298C alleles and folate status: a comparative study among Mexican, West African and West European populations. Am J Clin Nutr2006;83:701–7.10.1093/ajcn.83.3.701Search in Google Scholar PubMed

26. de Bree A, Verschuren WM, Blom HJ, Kromhout D. Association between B vitamin intake and plasma homocysteine concentration in the general Dutch population aged 20–65 y. Am J Clin Nutr2001;73:1027–33.10.1093/ajcn/73.6.1027Search in Google Scholar

27. Mennen LI, de Courcy GP, Guilland JC, Ducros V, Bertrais S, Nicolas JP. Homocysteine, cardiovascular disease risk factors, and habitual diet in the French Supplementation with Antioxidant Vitamins and Minerals Study. Am J Clin Nutr2002;76:1279–89.10.1093/ajcn/76.6.1279Search in Google Scholar

28. Eikelboom JW, Lonn E, Genest J Jr, Hankey G, Yusuf S. Homocyst(e)ine and cardiovascular disease: a critical review of the epidemiologic evidence. Ann Intern Med1999;131:363–75.10.7326/0003-4819-131-5-199909070-00008Search in Google Scholar

29. Cronin S, Furie K, Kelly P. Dose-related association of MTHFR 677T allele with risk of ischemic stroke: evidence from a cumulative meta-analysis. Stroke2005;36:1581–7.10.1161/01.STR.0000169946.31639.afSearch in Google Scholar

30. Bosco P, Guéant-Rodriguez RM, Anello G, Spada R, Romano A, Fajardo A, et al. Association of homocysteine (but not of MTHFR 677 C→T, MTR 2756 A→G, MTRR 66 A→G and TCN2 776 C→G) with ischemic cerebrovascular disease in Sicily. Thromb Haemost2006;96:154–9.10.1160/TH06-02-0082Search in Google Scholar

31. Kelly PJ, Shih VE, Kistler JP, Barron M, Lee H, Mandell R, et al. Low vitamin B6, but not homocyst(e)ine, is associated with increased risk of stroke/TIA in the era of folic acid grain fortification. Stroke2003;34:51–4.10.1161/01.STR.0000071109.23410.ABSearch in Google Scholar

32. Taylor LM Jr, Moneta GL, Sexton G J, Schuff RA, Porter JM. Prospective blinded study of the relationship between plasma homocysteine and progression of symptomatic peripheral arterial disease. J Vasc Surg1999;29:8–19.10.1016/S0741-5214(99)70345-9Search in Google Scholar

33. Merchant AT, Hu FB, Spiegelman D, Willett WC, Rimm EB, Ascherio A. The use of B vitamin supplements and peripheral arterial disease risk in men are inversely related. J Nutr2003;133:2863–7.10.1093/jn/133.9.2863Search in Google Scholar PubMed

34. Lewis SJ, Ebrahim S, Smith GD. Meta-analysis of MTHFR 677C→T polymorphism and coronary heart disease: does totality of evidence support causal role for homocysteine and preventive potential of folate? Br Med J2005;331:1053.10.1136/bmj.38611.658947.55Search in Google Scholar PubMed PubMed Central

35. Clarke R, Smith AD, Jobst KA, Refsum H, Sutton L, Ueland PM. Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease. Arch Neurol1998;55:1449–55.10.1001/archneur.55.11.1449Search in Google Scholar PubMed

36. McCaddon A, Davies G, Hudson P, Tandy S, Cattell H. Total serum homocysteine in senile dementia of Alzheimer type. Int J Geriatr Psychiatry1998;13:235–9.10.1002/(SICI)1099-1166(199804)13:4<235::AID-GPS761>3.0.CO;2-8Search in Google Scholar

37. Seshadri S, Beiser A, Selhub J, Jacques PF, Rosenberg IH, D'Agostino RB, et al. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med2002;346:476–83.10.1056/NEJMoa011613Search in Google Scholar

38. Anello G, Gueant-Rodriguez RM, Bosco P, Gueant JL, Romano A, Namour B. Homocysteine and methylenetetrahydrofolate reductase polymorphism in Alzheimer's disease. Neuroreport2004;15:859–61.10.1097/00001756-200404090-00025Search in Google Scholar

39. Buysschaert M, Dramais AS, Wallemacq PE, Hermans MP. Hyperhomocysteinemia in type 2 diabetes: relationship to macroangiopathy, nephropathy, and insulin resistance. Diabetes Care2000;23:1816–22.10.2337/diacare.23.12.1816Search in Google Scholar

40. Smulders YM, Rakic M, Slaats EH, Treskes M, Sijbrands EJ, Odekerken DA, et al. Fasting and post-methionine homocysteine levels in NIDDM. Determinants and correlations with retinopathy, albuminuria, and cardiovascular disease. Diabetes Care1999;22:125–32.10.2337/diacare.22.1.125Search in Google Scholar

41. Mazza A, Bossone E, Mazza F, Distante A. Reduced serum homocysteine levels in type 2 diabetes. Nutr Metab Cardiovasc Dis2005;15:118–24.10.1016/j.numecd.2004.03.001Search in Google Scholar

42. Hermans MP, Gala JL, Buysschaert M. The MTHFR CT polymorphism confers a high risk for stroke to both homozygous and heterozygous T allele carriers with type 2 diabetes. Diabet Med2006;23:529–36.10.1111/j.1464-5491.2006.01841.xSearch in Google Scholar

Published Online: 2007-02-01
Published in Print: 2007-02-01

©2007 by Walter de Gruyter Berlin New York

Articles in the same Issue

  1. Associations between folate, vitamin B12, homocysteine and pathologies related to aging: the need to consider complex nutrient-nutrient and gene-nutrient interactions and the functional and socio-economic determinants in population-based studies
  2. Hyperhomocysteinemia and cardiovascular risk in postmenopausal women: the role of folate supplementation
  3. Association of vitamin B12, folate and homocysteine with functional and pathological characteristics of the elderly in a mountainous village in Sicily
  4. Association of thyroid dysfunction with vitamin B12, folate and plasma homocysteine levels in the elderly: a population-based study in Sicily
  5. Desmond (Des) Kenny MSc MCB FICI FRCPath Eur Clin Chem, 1941–2006
  6. Antibodies to citrullinated peptides: a significant step forward in the early diagnosis of rheumatoid arthritis
  7. Patient hydration: a major source of laboratory uncertainty
  8. Determination of the hepatitis C virus subtype: comparison of sequencing and reverse hybridization assays
  9. Quantification of relative changes in specific mRNAs from frozen whole blood – methodological considerations and clinical implications
  10. HER-2 protein concentrations in breast cancer cells increase before immunohistochemical and fluorescence in situ hybridization analysis turn positive
  11. Distinct alleles of mannose-binding lectin (MBL) and surfactant proteins A (SP-A) in patients with chronic cavitary pulmonary aspergillosis and allergic bronchopulmonary aspergillosis
  12. Novel molecular defect in the platelet ADP receptor P2Y12 of a patient with haemorrhagic diathesis
  13. Retrospective study of monoclonal gammopathies detected in the clinical laboratory of a Spanish healthcare district: 14-year series
  14. Renal impairment compromises the use of total homocysteine and methylmalonic acid but not total vitamin B12 and holotranscobalamin in screening for vitamin B12 deficiency in the aged
  15. Diagnostic value of calculated testosterone indices in the assessment of polycystic ovary syndrome
  16. Amniotic fibronectin fragmentation and expression of its domains, sialyl and fucosyl glycotopes associated with pregnancy complicated by intrauterine infection
  17. Predicted influence of sample hematocrit on injected mass of internal standard in mass spectrometry assays utilizing simple protein precipitation for sample preparation
  18. Evaluation of cardiovascular risk factors and related clinical markers in healthy young Japanese adults
  19. Cardiac natriuretic peptides after myocardial infarction: relationship with infarct size, left ventricular function and remodelling assessed by 99mTc-sestamibi gated-single photon emission tomography
  20. Plasma homocysteine cutoff values for venous thrombosis
  21. Lipid transfer protein activities in subjects with impaired glucose tolerance
  22. Heat shock protein 70-1 gene expression in pediatric heart surgery using blood cardioplegia
  23. Biochemical reference intervals for sex hormones with a new AutoDelfia method in aged men
  24. The Italian External Quality Control Programme for cystic fibrosis molecular diagnosis: 4 years of activity
  25. Standardization of ischemia-modified albumin testing: adjustment for serum albumin
  26. Is simultaneous measurement of anti-thyroid peroxidase and anti-thyroglobulin antibodies clinically useful in patients with thyroid dysfunction?
  27. To the Editor: In reply to Nakano et al. Clin Chem Lab Med 2006;44(5):522–532
  28. To the Editor: Author reply; Nakano et al. Clin Chem Lab Med 2006;44(5):522–532
  29. Accreditation of medical laboratories in the European Union
  30. Prevalence-dependent decision limits for the early detection of type 2 diabetes mellitus in venous blood, venous plasma and capillary blood during glucose challenge
Downloaded on 30.12.2025 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2007.065/pdf
Scroll to top button